Clinical Course of Patients With Mediastinal Lymph Node Tuberculosis and Risk Factors for Paradoxical Responses.
Endosonography
Lymph Node Tuberculosis
Mediastinum
Paradoxical Response
Journal
Journal of Korean medical science
ISSN: 1598-6357
Titre abrégé: J Korean Med Sci
Pays: Korea (South)
ID NLM: 8703518
Informations de publication
Date de publication:
04 Dec 2023
04 Dec 2023
Historique:
received:
10
04
2023
accepted:
07
09
2023
medline:
7
12
2023
pubmed:
5
12
2023
entrez:
5
12
2023
Statut:
epublish
Résumé
Paradoxical responses (PR) occur more frequently in lymph node tuberculosis (LNTB) than in pulmonary tuberculosis and present difficulties in differential diagnosis of drug resistance, new infection, poor patient compliance, and adverse drug reactions. Although diagnosis of mediastinal LNTB has become much easier with the development of endosonography, limited information is available. The aim of this study was to investigate the clinical course of mediastinal LNTB and the risk factors associated with PR. Patients diagnosed with mediastinal LNTB via endosonography were evaluated retrospectively between October 2009 and December 2019. Multivariable logistic regression was applied to evaluate the risk factors associated with PR. Of 9,052 patients who underwent endosonography during the study period, 158 were diagnosed with mediastinal LNTB. Of these, 55 (35%) and 41 (26%) concurrently had pulmonary tuberculosis and extrapulmonary tuberculosis other than mediastinal LNTB, respectively. Of 125 patients who completed anti-tuberculosis treatment, 21 (17%) developed PR at a median of 4.4 months after initiation of anti-tuberculosis treatment. The median duration of anti-tuberculosis treatment was 6.3 and 10.4 months in patients without and with PR, respectively. Development of PR was independently associated with age < 55 years (adjusted odds ratio [aOR], 5.72; 95% confidence interval [CI], 1.81-18.14; As PR occurred in one of six patients with mediastinal LNTB during anti-tuberculosis treatment, physicians should pay attention to patients with risk factors (younger age, lymphocytopenia, and larger LN) at the time of diagnosis.
Sections du résumé
BACKGROUND
BACKGROUND
Paradoxical responses (PR) occur more frequently in lymph node tuberculosis (LNTB) than in pulmonary tuberculosis and present difficulties in differential diagnosis of drug resistance, new infection, poor patient compliance, and adverse drug reactions. Although diagnosis of mediastinal LNTB has become much easier with the development of endosonography, limited information is available. The aim of this study was to investigate the clinical course of mediastinal LNTB and the risk factors associated with PR.
METHODS
METHODS
Patients diagnosed with mediastinal LNTB via endosonography were evaluated retrospectively between October 2009 and December 2019. Multivariable logistic regression was applied to evaluate the risk factors associated with PR.
RESULTS
RESULTS
Of 9,052 patients who underwent endosonography during the study period, 158 were diagnosed with mediastinal LNTB. Of these, 55 (35%) and 41 (26%) concurrently had pulmonary tuberculosis and extrapulmonary tuberculosis other than mediastinal LNTB, respectively. Of 125 patients who completed anti-tuberculosis treatment, 21 (17%) developed PR at a median of 4.4 months after initiation of anti-tuberculosis treatment. The median duration of anti-tuberculosis treatment was 6.3 and 10.4 months in patients without and with PR, respectively. Development of PR was independently associated with age < 55 years (adjusted odds ratio [aOR], 5.72; 95% confidence interval [CI], 1.81-18.14;
CONCLUSION
CONCLUSIONS
As PR occurred in one of six patients with mediastinal LNTB during anti-tuberculosis treatment, physicians should pay attention to patients with risk factors (younger age, lymphocytopenia, and larger LN) at the time of diagnosis.
Identifiants
pubmed: 38050909
pii: 38.e348
doi: 10.3346/jkms.2023.38.e348
pmc: PMC10695755
doi:
Substances chimiques
Antitubercular Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e348Informations de copyright
© 2023 The Korean Academy of Medical Sciences.
Déclaration de conflit d'intérêts
The authors have no potential conflicts of interest to disclose.
Références
J Ultrasound Med. 2015 Sep;34(9):1645-50
pubmed: 26269299
J Thorac Dis. 2013 Oct;5(5):E189-94
pubmed: 24255790
Chest. 2002 Apr;121(4):1165-70
pubmed: 11948048
J Thorac Oncol. 2015 Feb;10(2):331-7
pubmed: 25611227
J Infect. 2022 Jan;84(1):17-23
pubmed: 34706281
Open Forum Infect Dis. 2019 Sep 03;6(10):ofz388
pubmed: 31660351
Clin Infect Dis. 2005 May 1;40(9):1368-71
pubmed: 15825042
Eur Respir J. 2017 Aug 24;50(2):
pubmed: 28838977
J Thorac Cardiovasc Surg. 1999 Nov;118(5):894-9
pubmed: 10534695
Int J Infect Dis. 2015 Mar;32:39-45
pubmed: 25809754
Ann Lab Med. 2012 Jul;32(4):264-9
pubmed: 22779067
BMJ Case Rep. 2017 Jul 31;2017:
pubmed: 28765480
Respir Med. 2017 Dec;133:6-11
pubmed: 29173450
Clin Infect Dis. 2009 Nov 1;49(9):1350-7
pubmed: 19793000
BMC Infect Dis. 2014 Jan 08;14:9
pubmed: 24400848
PLoS One. 2019 Aug 15;14(8):e0221232
pubmed: 31415659
Clin Infect Dis. 2011 Sep;53(6):555-62
pubmed: 21865192
Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1376-95
pubmed: 10764337
Chest. 2004 Jul;126(1):259-67
pubmed: 15249469
Thorax. 2004 Aug;59(8):704-7
pubmed: 15282393
Infect Chemother. 2017 Jun;49(2):130-134
pubmed: 28608659
Tuberc Respir Dis (Seoul). 2015 Apr;78(2):47-55
pubmed: 25861336
Ann Thorac Surg. 2013 Dec;96(6):2021-7
pubmed: 24035300
J Infect. 2009 Jul;59(1):56-61
pubmed: 19535147
Thorax. 2011 Oct;66(10):889-93
pubmed: 21813622
Am J Clin Pathol. 2014 Sep;142(3):384-90
pubmed: 25125630
PLoS One. 2014 Mar 14;9(3):e91893
pubmed: 24632834
Ann Thorac Surg. 2006 Oct;82(4):1185-9; discussion 1189-90
pubmed: 16996905
Respirology. 2019 Jul;24(7):667-674
pubmed: 30730098
J Clin Microbiol. 2015 Feb;53(2):696-8
pubmed: 25428157
Crit Care. 2004 Dec;8(6):508-12
pubmed: 15566624
Int J Tuberc Lung Dis. 2007 Dec;11(12):1290-5
pubmed: 18034948
AIDS. 2005 Jul 22;19(11):1201-6
pubmed: 15990574
Am J Respir Crit Care Med. 1998 Jul;158(1):157-61
pubmed: 9655723
Int J Tuberc Lung Dis. 2012 Jun;16(6):846-51
pubmed: 22507441
J Int Med Res. 2021 Jul;49(7):3000605211023696
pubmed: 34256638
Eur J Clin Microbiol Infect Dis. 2003 Oct;22(10):597-602
pubmed: 14508660
Tohoku J Exp Med. 2011;223(3):199-204
pubmed: 21372521
Ann Thorac Surg. 2000 Dec;70(6):2142-3
pubmed: 11156137
Int J Infect Dis. 2017 Jan;54:4-7
pubmed: 27810522
Eur J Cancer. 2009 Jan;45(2):261-7
pubmed: 19091550